You've probably seen the headlines about Ozempic and other GLP-1 drugs and Alzheimer's disease. One week it sounds like a breakthrough. The next, not so much. A large study found a much lower rate of Alzheimer's diagnoses in people taking these medications. Then a major clinical trial published this year found something very different. Neither one is wrong. And understanding why matters, especially if you're the one trying to make sense of it for your family. In this video I walk you through what the research on Ozempic and other GLP-1 drugs actually found, the meaningful difference between preventing this disease and treating it once it's already there, and what this means whether your loved one already has Alzheimer's or you're a caregiver thinking about your own brain health.

If you'd like to see this episode on video, you can hop on over to my YouTube channel here.

→ Join the Care Collective: https://tinyurl.com/podcast-cc

→ Get free weekly tools and tips in my newsletter, The Dementia Dose: https://tinyurl.com/dementiadose-podcast

⏱ CHAPTERS

0:00 - The Ozempic and Alzheimer's headlines everyone's seen

0:51 - The study that found a 40 to 70% lower Alzheimer's risk

2:09 - Why a diabetes drug could protect the brain

4:16 - The 2026 clinical trial that changed the picture

5:26 - Prevention vs. treatment: what the research actually means

#dementia #dementiacaregiver #ozempic #alzheimers #dementiaresearch

---

Hi, I'm Dr. Natali Edmonds, a board-certified geropsychologist specializing in dementia care. Whether your loved one has Alzheimer's, frontotemporal, Lewy body, vascular, or mixed dementia, we believe that to create a dementia-friendly world, we must first create a caregiver-friendly world.

This content is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for medical guidance.